Skip to content

Match study

Preventive extended red blood cell matching: when and how?

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28489
Enrollment
1120
Registered
2007-12-18
Start date
2008-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with a first or subsequent transfusion event, stratified for patients with alloantibodies after a previous transfusion. (NLD: Trefwoorden: Red blood cell antibodies, Erytrocyten antistoffen Preventive matching, Preventief matchen).

Interventions

Patients are randomly assigned to receive standard ABO-D matched or extended (C, E, c, e, K, Fya, Jka and S) matched RBC transfusions.

Sponsors

Sanquin Bloodbank Southwest Region
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The general transfusion population >18 years requiring an elective RBC transfusion.

Exclusion criteria

Exclusion criteria: 1. Patients younger than 18 years; 2. Patients with an a priori indication for matched transfusions; 3. Patients with a positive direct antiglobulin test; 4. Patients who, based on the local pre-operative blood-ordering list, require more than 4 units during surgery; 5. Incapacitated subjects or patients who cannot understand the information.

Design outcomes

Primary

MeasureTime frame
Incidence of alloimmunization in transfusion patients through preventive donor matching for the clinically relevant blood cell antigens compared to standard matching in patients stratified for high risk and random risk for alloimmunization.

Secondary

MeasureTime frame
Cost-analysis for current serologic screen and match strategy compared to preventive matching strategy in the two strata of patients. Health benefits: investigate transfusion and/or other medical treatment delay in case of RBC alloimmunization. Clinical and genetic factors associated with alloimmunization.

Contacts

Public ContactH. Schonewille

Sanquin Bloedbank Southwest region Plemanslaan 1a

h.schonewille@sanquin.nl071-5685069

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)